PHG has been the subject of a number of other research reports. Sanford C. Bernstein raised shares of Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a report on Tuesday, March 18th. BNP Paribas upgraded Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research report on Tuesday, February 25th. Finally, UBS Group raised shares of Koninklijke Philips from a “neutral” rating to a “buy” rating in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Check Out Our Latest Stock Analysis on PHG

PHG stock opened at $23.85 on Monday. The stock has a market capitalization of $22.42 billion, a PE ratio of -28.39, a price-to-earnings-growth ratio of 0.82 and a beta of 0.81. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.23 and a quick ratio of 0.74. The company has a 50 day moving average price of $24.52 and a 200 day moving average price of $25.72. Koninklijke Philips has a fifty-two week low of $21.48 and a fifty-two week high of $32.91.

Koninklijke Philips (NYSE:PHG – Get Free Report) last issued its earnings results on Tuesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.13. The company had revenue of $4.31 billion for the quarter, compared to analyst estimates of $4.10 billion. Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The company’s revenue for the quarter was down 1.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.21 EPS. Analysts forecast that Koninklijke Philips will post 1.63 EPS for the current year.

The firm also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Tuesday, May 13th will be given a $0.886 dividend. This represents a dividend yield of 2.9%. The ex-dividend date of this dividend is Tuesday, May 13th. Koninklijke Philips’s dividend payout ratio is presently 174.42%.

Several large investors have recently added to or reduced their stakes in the business. Colonial Trust Co SC grew its holdings in shares of Koninklijke Philips by 724.0% in the 4th quarter. Colonial Trust Co SC now owns 1,409 shares of the technology company’s stock valued at $36,000 after acquiring an additional 1,238 shares in the last quarter. Bessemer Group Inc. lifted its position in shares of Koninklijke Philips by 2,935.4% in the first quarter. Bessemer Group Inc. now owns 1,973 shares of the technology company’s stock valued at $51,000 after buying an additional 1,908 shares during the last quarter. Farther Finance Advisors LLC boosted its stake in shares of Koninklijke Philips by 37.1% during the 4th quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock worth $54,000 after acquiring an additional 582 shares during the period. Whipplewood Advisors LLC acquired a new position in shares of Koninklijke Philips during the 4th quarter worth approximately $55,000. Finally, Millstone Evans Group LLC bought a new stake in Koninklijke Philips in the 4th quarter valued at $60,000. Institutional investors and hedge funds own 13.67% of the company’s stock.

(Get Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.